← Back to Clinical Trials
Recruiting NCT06579950

NCT06579950 Assessing the Effects of Cool Roofs on Indoor Environments and Health

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06579950
Status Recruiting
Phase
Sponsor Aditi Bunker
Condition Resting Heart Rate
Study Type INTERVENTIONAL
Enrollment 3,200 participants
Start Date 2024-09-04
Primary Completion 2027-09-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Cool roof

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 3,200 participants in total. It began in 2024-09-04 with a primary completion date of 2027-09-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Ambient air temperatures in Asian, Latin American, African, and Pacific climate hotspots have broken record highs in 2024, driven by man-made climate change. Solutions are needed to reduce heat exposure in communities. Sunlight-reflecting cool roof coatings passively reduce indoor temperatures and energy use to protect home occupants from extreme heat. Occupants living in poor housing conditions globally - for example in informal settlements, slums, and low-socioeconomic households - are especially vulnerable to increased indoor heat exposure. Heat exposure can instigate and worsen numerous physical, mental and social health conditions. The worst adverse health effects are being experienced in communities least able to adapt to heat exposure. By reducing indoor temperatures, cool roof use can promote physical, mental and social wellbeing in occupants. The long-term research goal is to identify viable passive housing adaptation technologies with proven health and environmental benefits to reduce the burden of heat stress in communities affected by heat globally. To meet this goal, the investigators will conduct a cluster-randomized controlled trial to establish the effects of cool roof use on health, indoor environment and economic outcomes in five urban climate hotspots: Ouagadougou, Burkina Faso; Colima, Mexico; Ahmedabad, India; Niue; and Tavua, Fiji.

Eligibility Criteria

Inclusion Criteria: * Permanent household resident. Exclusion Criteria: * Roof damage, inaccessible or instability of roof adversely affecting cool roof coating application. * Participant unable to provide written/verbal informed consent.

Contact & Investigator

Central Contact

Aditi Bunker, Dr

✉ aditi.bunker@uni-heidelberg.de

📞 +49 6221 565344

Principal Investigator

Collin Tukuitonga, Sir. Dr.

PRINCIPAL INVESTIGATOR

University of Auckland, New Zealand

Frequently Asked Questions

Who can join the NCT06579950 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Resting Heart Rate. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06579950 currently recruiting?

Yes, NCT06579950 is actively recruiting participants. Contact the research team at aditi.bunker@uni-heidelberg.de for enrollment information.

Where is the NCT06579950 trial being conducted?

This trial is being conducted at Ouagadougou, Burkina Faso, Suva, Fiji, Ahmedabad, India, Hermosillo, Mexico and 1 additional location.

Who is sponsoring the NCT06579950 clinical trial?

NCT06579950 is sponsored by Aditi Bunker. The principal investigator is Collin Tukuitonga, Sir. Dr. at University of Auckland, New Zealand. The trial plans to enroll 3,200 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology